Evidence map›Paper›PMID 39690316›Full record

ArticleDiscover nano2024

Comparative impacts of myco-synthesized nanoparticles against strains of Aspergillus spp. causing biodeterioration of stored cocoa beans in Nigeria.

Olayinka Oluyemi Oluranti, Babatunde Ayodeji Ogundeji, Samuel Bukola Orisajo

Abstract read
In one paragraph

Article in Discover nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olayinka Oluyemi OlurantiMicrobiology Programme, Bowen University, Iwo, Osun State, Nigeria.
Babatunde Ayodeji OgundejiPlant Pathology Section, Cocoa Research Institute of Nigeria, Ibadan, Oyo State, Nigeria. tundeji1@gmail.com.
Samuel Bukola OrisajoPlant Pathology Section, Cocoa Research Institute of Nigeria, Ibadan, Oyo State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver nanoparticle solutions (AgNPs) of some mushrooms: Pleurotus ostreatus, Agaricus bisporus and Agaricus campestris were prepared and characterized using Transmission Electron Microscopy (TEM), Fourier-Transform Infrared (FTIR) spectroscopy, X-Ray Diffraction (XRD) analysis and Energy Dispersive X-ray (EDX) spectroscopy. Each of the myco-sythesized AgNPs was plated against strains of Aspergillus flavus and A. ochraceous, at 5, 10 and 15% concentrations. Colour change from light yellow to orange, yellowish-brown, and reddish brown was observed after overnight incubation (at 28 °C), in the P. ostreatus, A. bisporus, and A. campestris synthesized AgNPs respectively. TEM analysis showed a spherical shape with an average size of 15.25 to 45.85 nm, 9.22 to 52.60 nm and 10.24 to 17.66 nm in P. ostreatus, A. campestris and A. bisporus AgNPs respectively. EDX spectrum showed absorption peaks of silver in the ranges of 0.8-1.4 keV, 6.2-6.6 keV, and 0.8-1.2 keV, and XRD analysis confirmed the crystalline structure of the biosynthesized AgNPs, while FTIR results revealed O-H, N-H, C=O, and C=N as the prominent functional groups. Mycelial inhibitions against A. flavus strains D28AF and D42AF ranged between 43.86-52.73% and 33.83-57.07% respectively, and were not significantly different (P ≤ 0.05) from the standard (copper sulphate). Inhibitions produced against A. ochraceous strains AOD40 and AOD45 ranged between 34.64-52.36% and 37.43-53.56% respectively and also showed similar trend in relation to the standard. This study showed that the myco-synthesized AgNPs were effective against A. flavus and A. ochraceous infecting cocoa beans at storage. They however need to be further improved for future use in the control of cocoa beans pathogens.

Indexed as

AgaricusAntifungalInhibitionMyco-synthesisPleurotus

Identifiers

PMID39690316
PMCPMC11652509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.